2023 Trends in New Drug Development
The webinar features panelists from Columbia University, Janssen, Syntekabio (KOSDAQ:226330.KQ) and Auctus Capital New York, N.Y. —News Direct— Syntekabio, Inc. Syntekabio (KOSDAQ:226330.KQ)(226...
- Supported exchanges /
- KQ /
- 226330.KQ
SyntekaBio Inc (226330 KQ) stock market data APIs
₩6470
-680(-9.5%)
as of November 25, 2024
Price chart is built with Anychart
SyntekaBio, Inc. operates as a genomic big data and artificial intelligence drug discovery company. It creates new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology, such as biomarkers for individual cancer drug screening and disease susceptibility by immunotyping, pharmacogenomic typing, and predicting multi-omics information-based drug adverse effects, etc. The company also developing new antigen prediction technology that can be used together with therapeutic vaccines and cell therapy products, and prediction of antibody therapeutics. SyntekaBio, Inc. was founded in 2009 and is headquartered in Daejeon, South Korea.
SyntekaBio Inc Financial Data Overview
| 7150 | |
| 6470 | |
| - | |
| 7150 | |
| 6470 | |
| 4195-14880 | |
| 104 063 M | |
| 15 259 K | |
| 124 M | |
| -174.1318 | |
| 0.616 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'226330',
Type:
'Common Stock',
Name:
'SyntekaBio Inc',
Exchange:
'KQ',
CurrencyCode:
'KRW',
CurrencyName:
'Korean Won',
CurrencySymbol:
'₩',
CountryName:
'Korea',
CountryISO:
'KR',
OpenFigi:
'BBG00QT56L24',
ISIN:
'KR7226330009',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Health Information Services',
}
SyntekaBio Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 124 M
- EBITDA -10 724 551 680
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get SyntekaBio Inc Earnings via APIs
- Latest Release 2024-09-30
- EPS/Forecast NaN
Get SyntekaBio Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get SyntekaBio Inc latest news via APIs
New Cloud Platform “STB CLOUD” Disrupts AI Drug Discovery Worldwide (KOSDAQ:226330.KQ)
- DISCOVERY PLATFORM
- DRUG CANDIDATES
- DRUG DISCOVERY
- STB CLOUD
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
